Study findings suggest that ixekizumab provides balanced joint and skin improvements with comparable treatment persistence to other b/tsDMARDs in routine PsA care.

Objective Although socioeconomic status has been linked to various rheumatoid arthritis (RA)-related outcomes, evidence on ...

Please provide your email address to receive an email when new articles are posted on . Rheumatoid arthritis and gout may overlap more than traditionally thought. Rheumatoid arthritis, specifically ...

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. There is also currently no ...

Dr. Deane has received grant funding from the Arthritis Foundation, the National Institutes of Health, Boehringer Ingelheim, Gilead and ThermoFisher, and has had consulting/advisory board ...

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but their relative effects on pain, versus inflammation, are less ...

Rheumatoid arthritis (RA) is an autoimmune disease that causes swelling, stiffness, and inflammation in the joints as the immune system attacks its own body’s tissues. And while diet alone can’t treat ...

Between 5% and 20% of individuals with chikungunya infection develop chronic arthritis that is indistinguishable from rheumatoid arthritis (RA). Management typically follows the same approach used ...

Rheumatoid arthritis begins years before pain ever appears, and scientists have now mapped the hidden immune battle that unfolds long before symptoms. By studying people with RA-linked antibodies over ...

Getting your Trinity Audio player ready... People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early ...